Last 12 months
Inside the activity.
0 purchase rows · 38 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 22 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 02, 2018 Filed Aug 6, 2018 22:00 UTC |
Zaderej Karen L.Director · CEO
|
Exercise / conversionStock Option (right to purchase) · Derivative | 175,000 | $0.00 Strike: $2.74 | $0.00 |
DisclosureSEC source: 0001179110-18-010330 · edgar.xml · derivative · entry 2 Zaderej Karen L. · CIK 0001530968 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 175,000 shares Expires 2018-12-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 22:00 UTC |
Zaderej Karen L.Director · CEO
|
Exercise / conversionCommon Stock | 175,000 | $2.74 | $479,500.00 |
DisclosureSEC source: 0001179110-18-010330 · edgar.xml · nonDerivative · entry 1 Zaderej Karen L. · CIK 0001530968 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 418,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 09, 2018 Filed Jul 11, 2018 21:05 UTC |
COLLERAN LISA NDirector
|
GrantStock Option (right to purchase) · Derivative | 3,916 | $0.00 Strike: $53.65 | $0.00 |
DisclosureSEC source: 0001179110-18-009630 · edgar.xml · derivative · entry 2 COLLERAN LISA N · CIK 0001212312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,916 Underlying: Common Stock · 3,916 shares Expires 2028-07-09 F2 · derivative.exercise_date: Annual option grant for director of Issuer's Board of Directors, pro-rated for joining Board of Directors during annual period. Option vests quarterly with all shares vested June 1, 2019 in conformity with vesting for such annual director grants. Read SEC document |
| July 09, 2018 Filed Jul 11, 2018 21:05 UTC |
COLLERAN LISA NDirector
|
GrantStock Option (right to purchase) · Derivative | 9,134 | $0.00 Strike: $53.65 | $0.00 |
DisclosureSEC source: 0001179110-18-009630 · edgar.xml · derivative · entry 1 COLLERAN LISA N · CIK 0001212312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,134 Underlying: Common Stock · 9,134 shares Expires 2028-07-09 F1 · derivative.exercise_date: Option grant for joining the Issuer's Board of Directors. Options vest quarterly as to 12.5% of total share amount beginning with the first vesting date on October 9, 2018 and becoming fully vested July 9, 2020 (two years after grant). Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 20:42 UTC |
Rudelius Robert JamesDirector
|
Exercise / conversionDirector Stock Option (right to purchase) · Derivative | 12,000 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001179110-18-008396 · edgar.xml · derivative · entry 3 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2018-10-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 20:42 UTC |
Rudelius Robert JamesDirector
|
Tax withholdingCommon Stock | 682 | $48.40 | $33,008.80 |
DisclosureSEC source: 0001179110-18-008396 · edgar.xml · nonDerivative · entry 2 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,591 F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 12,000 shares by means of a cashless exercise. A cashless exercise is a method of exercising a stock option in which the option holder pays the exercise price using shares the reporting person would have received pursuant to the option exercise. As a result of this cashless exercise, the Reporting Person, on a net basis, acquired ownership of an additional 11,318 shares of common stock. Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 20:42 UTC |
Rudelius Robert JamesDirector
|
Exercise / conversionCommon Stock | 12,000 | $2.75 | $33,000.00 |
DisclosureSEC source: 0001179110-18-008396 · edgar.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 12,000 shares by means of a cashless exercise. A cashless exercise is a method of exercising a stock option in which the option holder pays the exercise price using shares the reporting person would have received pursuant to the option exercise. As a result of this cashless exercise, the Reporting Person, on a net basis, acquired ownership of an additional 11,318 shares of common stock. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:11 UTC |
Wendell Amy McBrideDirector
|
GrantStock Option (right to purchase) · Derivative | 4,780 | $0.00 Strike: $49.65 | $0.00 |
DisclosureSEC source: 0001179110-18-008113 · edgar.xml · derivative · entry 1 Wendell Amy McBride · CIK 0001400568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,780 Underlying: Common Stock · 4,780 shares Expires 2028-06-01 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Options vest in equal installments every three months for the first nine months, with the final installment vesting on the earlier of the date of the 2019 annual shareholders meeting or May 31, 2019. Number of shares pursuant to option are based on $120,000 valuation as of the grant date. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:11 UTC |
Grooms Jamie MarkDirector
|
GrantStock Option (right to purchase) · Derivative | 4,780 | $0.00 Strike: $49.65 | $0.00 |
DisclosureSEC source: 0001179110-18-008111 · edgar.xml · derivative · entry 1 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,780 Underlying: Common Stock · 4,780 shares Expires 2028-06-01 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Options vest in equal installments every three months for the first nine months, with the final installment vesting on the earlier of the date of the 2019 annual shareholders meeting or May 31, 2019. Number of shares pursuant to option are based on $120,000 valuation as of the grant date. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:02 UTC |
Gold Mark StephenDirector
|
GrantStock Option (right to purchase) · Derivative | 4,780 | $0.00 Strike: $49.65 | $0.00 |
DisclosureSEC source: 0001179110-18-008099 · edgar.xml · derivative · entry 3 Gold Mark Stephen · CIK 0001531332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,780 Underlying: Common Stock · 4,780 shares Expires 2028-06-01 F2 · derivative.exercise_date: Non-qualified stock option grant for service as Director on the Company's Board of directors. Options vest in equal installments every three months for the first nine months, with the finalinstallment vesting on the earlier of the date of the 2019 annual shareholders meeting or May 31, 2019. Number of shares pursuant to option are based on $120,000 valuation as of the grantdate. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:02 UTC |
Gold Mark StephenDirector
|
Exercise / conversionStock Option (right to purchase) · Derivative | 15,000 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001179110-18-008099 · edgar.xml · derivative · entry 2 Gold Mark Stephen · CIK 0001531332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2027-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:02 UTC |
Gold Mark StephenDirector
|
Exercise / conversionCommon Stock | 15,000 | $14.85 | $222,750.00 |
DisclosureSEC source: 0001179110-18-008099 · edgar.xml · nonDerivative · entry 1 Gold Mark Stephen · CIK 0001531332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The shares of common stock for Dr. Gold include 212,761 shares held jointly by Dr. Gold and his wife, indirect ownership of 20,000 shares held by Dr. Gold's spouse and indirect ownership of 122,487 shares held by MJSK, Ltd., a decedent investment trust held by Dr. Gold's family. F1 · ownership.direct: The shares of common stock for Dr. Gold include 212,761 shares held jointly by Dr. Gold and his wife, indirect ownership of 20,000 shares held by Dr. Gold's spouse and indirect ownership of 122,487 shares held by MJSK, Ltd., a decedent investment trust held by Dr. Gold's family. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:01 UTC |
NEELS GUIDO JDirector
|
GrantStock Option (right to purchase) · Derivative | 4,780 | $0.00 Strike: $49.65 | $0.00 |
DisclosureSEC source: 0001179110-18-008096 · edgar.xml · derivative · entry 1 NEELS GUIDO J · CIK 0001222362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,780 Underlying: Common Stock · 4,780 shares Expires 2028-06-01 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Options vest in equal installments every three months for the first nine months, with the final installment vesting on the earlier of the date of the 2019 annual shareholders meeting or May 31, 2019. Number of shares pursuant to option are based on $120,000 valuation as of the grant date. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:00 UTC |
Rudelius Robert JamesDirector
|
GrantStock Option (right to purchase) · Derivative | 4,780 | $0.00 Strike: $49.65 | $0.00 |
DisclosureSEC source: 0001179110-18-008092 · edgar.xml · derivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,780 Underlying: Common Stock · 4,780 shares Expires 2028-06-01 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Options vest in equal installments every three months for the first nine months, with the final installment vesting on the earlier of the date of the 2019 annual shareholders meeting or May 31, 2019. Number of shares pursuant to option are based on $120,000 valuation as of the grant date. Read SEC document |
| May 16, 2018 Filed May 18, 2018 22:25 UTC |
MCCARREY SHAWN FSVP Sales
|
SaleCommon Stock | 10,000 | $43.47 | $434,700.00 |
DisclosureSEC source: 0001179110-18-007135 · edgar.xml · nonDerivative · entry 1 MCCARREY SHAWN F · CIK 0001195924 · SVP Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,057 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.95 to $43.95. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 26, 2018 Filed Mar 27, 2018 22:45 UTC |
Donovan Michael PatrickVP Operations
|
Exercise / conversionEmployee Stock Option (right to purchase) · Derivative | 35,000 | $0.00 Strike: $2.74 | $0.00 |
DisclosureSEC source: 0001179110-18-004869 · edgar.xml · derivative · entry 3 Donovan Michael Patrick · CIK 0001653918 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 30,000 shares Expires 2018-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 26, 2018 Filed Mar 27, 2018 22:45 UTC |
Donovan Michael PatrickVP Operations
|
Tax withholdingCommon Stock | 2,042 | $40.25 | $82,190.50 |
DisclosureSEC source: 0001179110-18-004869 · edgar.xml · nonDerivative · entry 2 Donovan Michael Patrick · CIK 0001653918 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,617 F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 30,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 27,958 shares of common stock. Read SEC document |
| March 26, 2018 Filed Mar 27, 2018 22:45 UTC |
Donovan Michael PatrickVP Operations
|
Exercise / conversionCommon Stock | 30,000 | $2.74 | $82,200.00 |
DisclosureSEC source: 0001179110-18-004869 · edgar.xml · nonDerivative · entry 1 Donovan Michael Patrick · CIK 0001653918 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 30,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 27,958 shares of common stock. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 22:13 UTC |
Hansen David KVP Finance & Treasurer
|
Exercise / conversionEmployee Stock Option (right to purchase) · Derivative | 1,500 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001179110-18-004842 · edgar.xml · derivative · entry 6 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2019-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 22:13 UTC |
Hansen David KVP Finance & Treasurer
|
Exercise / conversionEmployee Stock Option (right to purchase) · Derivative | 35,000 | $0.00 Strike: $2.74 | $0.00 |
DisclosureSEC source: 0001179110-18-004842 · edgar.xml · derivative · entry 5 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,000 shares Expires 2018-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 22:13 UTC |
Hansen David KVP Finance & Treasurer
|
Tax withholdingCommon Stock | 104 | $39.55 | $4,113.20 |
DisclosureSEC source: 0001179110-18-004842 · edgar.xml · nonDerivative · entry 4 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,792 F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 36,500 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 33,971 shares of common stock. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 22:13 UTC |
Hansen David KVP Finance & Treasurer
|
Exercise / conversionCommon Stock | 1,500 | $2.75 | $4,125.00 |
DisclosureSEC source: 0001179110-18-004842 · edgar.xml · nonDerivative · entry 3 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 36,500 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 33,971 shares of common stock. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 22:13 UTC |
Hansen David KVP Finance & Treasurer
|
Tax withholdingCommon Stock | 2,425 | $39.55 | $95,908.75 |
DisclosureSEC source: 0001179110-18-004842 · edgar.xml · nonDerivative · entry 2 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,396 F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 36,500 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 33,971 shares of common stock. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 22:13 UTC |
Hansen David KVP Finance & Treasurer
|
Exercise / conversionCommon Stock | 35,000 | $2.74 | $95,900.00 |
DisclosureSEC source: 0001179110-18-004842 · edgar.xml · nonDerivative · entry 1 Hansen David K · CIK 0001362545 · VP Finance & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 36,500 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 33,971 shares of common stock. Read SEC document |
| March 21, 2018 Filed Mar 23, 2018 12:44 UTC |
Freitag Gregory GeneDirector · General Counsel & SVP BD
|
Exercise / conversionEmployee Stock Option (right to purchase) · Derivative | 15,000 | $0.00 Strike: $4.81 | $0.00 |
DisclosureSEC source: 0001179110-18-004789 · edgar.xml · derivative · entry 6 Freitag Gregory Gene · CIK 0001492710 · Director · General Counsel & SVP BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2021-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 21, 2018 Filed Mar 23, 2018 12:44 UTC |
Freitag Gregory GeneDirector · General Counsel & SVP BD
|
Exercise / conversionEmployee Stock Option (right to purchase) · Derivative | 16,000 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001179110-18-004789 · edgar.xml · derivative · entry 5 Freitag Gregory Gene · CIK 0001492710 · Director · General Counsel & SVP BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2021-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 21, 2018 Filed Mar 23, 2018 12:44 UTC |
Freitag Gregory GeneDirector · General Counsel & SVP BD
|
Tax withholdingCommon Stock | 1,874 | $38.50 | $72,149.00 |
DisclosureSEC source: 0001179110-18-004789 · edgar.xml · nonDerivative · entry 4 Freitag Gregory Gene · CIK 0001492710 · Director · General Counsel & SVP BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,865 F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 31,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 28,104 shares of common stock. Read SEC document |
| March 21, 2018 Filed Mar 23, 2018 12:44 UTC |
Freitag Gregory GeneDirector · General Counsel & SVP BD
|
Exercise / conversionCommon Stock | 15,000 | $4.81 | $72,150.00 |
DisclosureSEC source: 0001179110-18-004789 · edgar.xml · nonDerivative · entry 3 Freitag Gregory Gene · CIK 0001492710 · Director · General Counsel & SVP BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 31,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 28,104 shares of common stock. Read SEC document |
| March 21, 2018 Filed Mar 23, 2018 12:44 UTC |
Freitag Gregory GeneDirector · General Counsel & SVP BD
|
Tax withholdingCommon Stock | 1,022 | $38.50 | $39,347.00 |
DisclosureSEC source: 0001179110-18-004789 · edgar.xml · nonDerivative · entry 2 Freitag Gregory Gene · CIK 0001492710 · Director · General Counsel & SVP BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,739 F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 31,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 28,104 shares of common stock. Read SEC document |
| March 21, 2018 Filed Mar 23, 2018 12:44 UTC |
Freitag Gregory GeneDirector · General Counsel & SVP BD
|
Exercise / conversionCommon Stock | 16,000 | $2.46 | $39,360.00 |
DisclosureSEC source: 0001179110-18-004789 · edgar.xml · nonDerivative · entry 1 Freitag Gregory Gene · CIK 0001492710 · Director · General Counsel & SVP BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,761 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 31,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 28,104 shares of common stock. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:27 UTC |
Freitag Gregory GeneDirector · General Counsel & SVP BD
|
Exercise / conversionEmployee Stock Option (right to purchase) · Derivative | 36,000 | $0.00 Strike: $2.74 | $0.00 |
DisclosureSEC source: 0001179110-18-003516 · edgar.xml · derivative · entry 3 Freitag Gregory Gene · CIK 0001492710 · Director · General Counsel & SVP BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,000 shares Expires 2018-12-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:27 UTC |
Freitag Gregory GeneDirector · General Counsel & SVP BD
|
Tax withholdingCommon Stock | 2,905 | $33.95 | $98,624.75 |
DisclosureSEC source: 0001179110-18-003516 · edgar.xml · nonDerivative · entry 2 Freitag Gregory Gene · CIK 0001492710 · Director · General Counsel & SVP BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,761 F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 36,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 33,095 shares of common stock. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:27 UTC |
Freitag Gregory GeneDirector · General Counsel & SVP BD
|
Exercise / conversionCommon Stock | 36,000 | $2.74 | $98,640.00 |
DisclosureSEC source: 0001179110-18-003516 · edgar.xml · nonDerivative · entry 1 Freitag Gregory Gene · CIK 0001492710 · Director · General Counsel & SVP BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 36,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 33,095 shares of common stock. Read SEC document |
| February 21, 2018 Filed Feb 24, 2018 00:08 UTC |
Grooms Jamie MarkDirector
|
SaleCommon Stock | 57,406 | $28.40 | $1,630,330.40 |
DisclosureSEC source: 0001104659-18-011770 · a4.xml · nonDerivative · entry 1 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 372 F3 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017. F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.80 to $28.50. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 00:52 UTC |
Grooms Jamie MarkDirector
|
SaleCommon Stock | 36,740 | $27.90 | $1,025,046.00 |
DisclosureSEC source: 0001104659-18-010876 · a4.xml · nonDerivative · entry 2 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 62,861 F4 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.10 to $28.20. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 00:52 UTC |
Grooms Jamie MarkDirector
|
SaleCommon Stock | 26,655 | $27.35 | $729,014.25 |
DisclosureSEC source: 0001104659-18-010876 · a4.xml · nonDerivative · entry 1 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 99,601 F4 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017. F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.10 to $27.65. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 12:55 UTC |
MCCARREY SHAWN FSVP Sales
|
Tax withholdingCommon Stock | 3,260 | $27.40 | $89,324.00 |
DisclosureSEC source: 0001179110-18-002334 · edgar.xml · nonDerivative · entry 2 MCCARREY SHAWN F · CIK 0001195924 · SVP Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,057 Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 12:55 UTC |
MCCARREY SHAWN FSVP Sales
|
GrantCommon Stock | 7,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002334 · edgar.xml · nonDerivative · entry 1 MCCARREY SHAWN F · CIK 0001195924 · SVP Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,317 F1 · shares: Represents shares of common stock that have vested and settled in accordance with that certain PSU Agreement granted to the reporting person on December 29, 2016. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 00:56 UTC |
Grooms Jamie MarkDirector · VP, CFO
|
SaleCommon Stock | 43,403 | $27.11 | $1,176,655.33 |
DisclosureSEC source: 0001104659-18-010127 · a4.xml · nonDerivative · entry 5 Grooms Jamie Mark · CIK 0001530935 · Director · VP, CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 126,256 F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.50 to $27.375. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 15, 2018 Filed Feb 17, 2018 01:14 UTC Amendment |
Grooms Jamie MarkDirector
|
SaleCommon Stock | 43,403 | $27.11 | $1,176,655.33 |
DisclosureSEC source: 0001104659-18-010448 · a4a.xml · nonDerivative · entry 5 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 126,256 F8 · kind: The transactions reported on the original Form 4 filed on February 15, 2018 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017. F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.50 to $27.375. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 00:56 UTC |
Grooms Jamie MarkDirector · VP, CFO
|
SaleCommon Stock | 9,073 | $26.71 | $242,339.83 |
DisclosureSEC source: 0001104659-18-010127 · a4.xml · nonDerivative · entry 4 Grooms Jamie Mark · CIK 0001530935 · Director · VP, CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.20 to $26.95. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Children's Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 00:56 UTC |
Grooms Jamie MarkDirector · VP, CFO
|
SaleCommon Stock | 32,936 | $26.72 | $880,049.92 |
DisclosureSEC source: 0001104659-18-010127 · a4.xml · nonDerivative · entry 3 Grooms Jamie Mark · CIK 0001530935 · Director · VP, CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 169,659 F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.10 to $27.05. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 01:14 UTC Amendment |
Grooms Jamie MarkDirector
|
SaleCommon Stock | 9,073 | $26.71 | $242,339.83 |
DisclosureSEC source: 0001104659-18-010448 · a4a.xml · nonDerivative · entry 4 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F8 · kind: The transactions reported on the original Form 4 filed on February 15, 2018 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.20 to $26.95. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Children's Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 01:14 UTC Amendment |
Grooms Jamie MarkDirector
|
SaleCommon Stock | 32,936 | $26.72 | $880,049.92 |
DisclosureSEC source: 0001104659-18-010448 · a4a.xml · nonDerivative · entry 3 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 169,659 F8 · kind: The transactions reported on the original Form 4 filed on February 15, 2018 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.10 to $27.05. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 13, 2018 Filed Feb 16, 2018 00:56 UTC |
Grooms Jamie MarkDirector · VP, CFO
|
SaleCommon Stock | 3,200 | $26.22 | $83,904.00 |
DisclosureSEC source: 0001104659-18-010127 · a4.xml · nonDerivative · entry 2 Grooms Jamie Mark · CIK 0001530935 · Director · VP, CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 9,073 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.60. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Children's Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 13, 2018 Filed Feb 16, 2018 00:56 UTC |
Grooms Jamie MarkDirector · VP, CFO
|
SaleCommon Stock | 7,100 | $26.20 | $186,020.00 |
DisclosureSEC source: 0001104659-18-010127 · a4.xml · nonDerivative · entry 1 Grooms Jamie Mark · CIK 0001530935 · Director · VP, CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 202,595 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.55. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 13, 2018 Filed Feb 17, 2018 01:14 UTC Amendment |
Grooms Jamie MarkDirector
|
SaleCommon Stock | 3,200 | $26.22 | $83,904.00 |
DisclosureSEC source: 0001104659-18-010448 · a4a.xml · nonDerivative · entry 2 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 9,073 F8 · kind: The transactions reported on the original Form 4 filed on February 15, 2018 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.60. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Children's Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 13, 2018 Filed Feb 17, 2018 01:14 UTC Amendment |
Grooms Jamie MarkDirector
|
SaleCommon Stock | 7,100 | $26.20 | $186,020.00 |
DisclosureSEC source: 0001104659-18-010448 · a4a.xml · nonDerivative · entry 1 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 202,595 F8 · kind: The transactions reported on the original Form 4 filed on February 15, 2018 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017. F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.55. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee. Read SEC document |
| December 30, 2017 Filed Mar 14, 2017 23:31 UTC |
Freitag Gregory GeneDirector · General Counsel & SVP BD
|
Exercise / conversionEmployee Stock Option (right to purchase) · Derivative | 23,000 | $0.00 Strike: $2.74 | $0.00 |
DisclosureSEC source: 0001179110-17-004608 · edgar.xml · derivative · entry 2 Freitag Gregory Gene · CIK 0001492710 · Director · General Counsel & SVP BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,000 Underlying: Common Stock · 92,000 shares Expires 2018-12-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 23:55 UTC |
Freitag Gregory GeneDirector · General Counsel & SVP BD
|
GrantRestricted Stock Units · Derivative | 3,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-015746 · edgar.xml · derivative · entry 2 Freitag Gregory Gene · CIK 0001492710 · Director · General Counsel & SVP BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,700 Underlying: Common Stock · 3,700 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of AxoGen, Inc. common stock. F3 · derivative.exercise_date: All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 18, 2021 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date. F3 · derivative.expiration_date: All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 18, 2021 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.